10x Genomics Celebrates Opening of Singapore Manufacturing and Trade Hub

Strengthens supply chain continuity with the first manufacturing facility outside the United States

Posted: October 25, 2021 at 5:00 a.m. CDT|Update: 9 minutes ago

SINGAPORE, 25 October 2021 / PRNewswire / – 10x Genomics (Nasdaq: TXG), a leader in life sciences focused on harnessing biology to advance human health, today marked a milestone Asia Pacific (APAC) with the celebration of the inauguration of its Singapore manufacturing plant and shopping center.

The addition of the company’s first manufacturing facility outside of the United States is part of 10x Genomics’ continued investments to integrate and evolve its operating network to build a more robust supply chain and better serve its customers around the world. The manufacturing center provides additional capacity for 10x Genomics’ leading consumable portfolio for unicellular and spatial analysis. The site also serves as an APAC business hub, strengthening the company’s sales, marketing and customer support capabilities in the region.

10x Genomics’ Singapore The hub occupies more than 53,000 square feet of the Solaris @ Kallang 164 complex, including state-of-the-art automated production suites for reagent manufacturing and a fully equipped Level 2 biosafety lab for training customers and operators. partners on all 10x Genomics cellular and space technologies. The site, which began its initial operations in late 2020, also includes a distribution center, warehousing space and open office spaces that encourage collaboration and teamwork. 10x Genomics currently employs over 80 people in Singapore in manufacturing, corporate functions and business roles.

As 10x Genomics continues to expand its global reach, the Asia Pacific The region is an important market for the company, accounting for 25% of global sales in the first half of 2021.

10x Selected genomics Singapore as the ideal location for its expansion due to the Singapore Government’s demonstrated commitment to the biotechnology industry and business-friendly practices, world-class manufacturing expertise and a strong talent pool.

Singapore is a global biotechnology hub with a thriving innovation ecosystem and a strong research community, ”said Serge Saxonov, co-founder and CEO of 10x Genomics. “We sincerely thank the Economic Development Council for Singapore for their incredible support and partnership and the 10x teams in Singapore and California for their considerable efforts in bringing this site online. We are delighted to increase our presence here and are delighted to contribute to that of Singapore culture of science and innovation as we strive to deliver on the promise of this century of biology. “

“10x Genomics” Singapore The manufacturing plant and shopping center will be a dynamic addition to our life science ecosystem, and we look forward to continuing our strong partnership with the company. The life sciences sector is an important pillar of our healthcare industry and has a promising growth trajectory. The Economic Development Council remains committed to supporting innovation and manufacturing activities in this sector, which will create good jobs and business opportunities in Singapore, said Ms. Goh Wan Yee, Senior Vice President and Head, Health, Economic Development Council of Singapore.

About 10x the genomics

10x Genomics is a life science technology company that manufactures products to interrogate, understand and harness biology to advance human health. The company’s integrated solutions include instruments, consumables, and software to analyze biological systems at a resolution and scale that match the complexity of biology. 10x genomics have been adopted by researchers around the world, including in the top 100 global research institutions ranked by Nature in 2020 based on publications and all of the top 20 global pharmaceutical companies by 2020 are spending on research and development and have been cited in over 2,800 research papers on discoveries ranging from oncology to immunology and neuroscience. The company’s patent portfolio includes more than 1,150 issued patents and patent applications.

Disclosure Information

10x Genomics uses documents filed with the Securities and Exchange Commission, its website (www.10xgenomics.com), press releases, public conference calls, public webcasts, and its social media accounts as a means of disclosing material non-public information and complying with its disclosure obligations under the FD Regulation.


Investors: [email protected]

Media: [email protected]

Show original content:

SOURCE 10x Genomics, Inc.

The above press release has been provided courtesy of PRNewswire. The views, opinions and statements contained in the press release are not endorsed by Gray Media Group and do not necessarily state or reflect those of Gray Media Group, Inc.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *